Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Status:
Terminated
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if using a lower dose of chemotherapy before stem
cell transplantation can cure patients of sickle cell anemia or thalassemia while causing
fewer severe side effects than conventional high dose chemotherapy with transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)